相关实验视频

Updated: Jan 15, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

GSTP1改善了CAR-T细胞的增殖和细胞毒性,以对抗淋巴瘤

Guangsong Xu¹, Jiani Wang¹, Yuliang Qu¹

¹College of Laboratory Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.

Frontiers in immunology

|October 13, 2025

概括

在CAR-T细胞中过度表达氨酸S转移酶Pi-1 (GSTP1) 通过减少活性氧物种 (ROS) 来对抗疲劳. 这增强了CAR-T细胞的抗瘤活性,并为免疫治疗提供了新的策略.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
癌症治疗癌症治疗

背景情况:

化学抗原受体T细胞 (CAR-T) 治疗疗效受到T细胞耗尽的限制.
持续的抗原刺激会增加活性氧物种 (ROS),损害T细胞功能.
谷氨酸S转移酶Pi-1 (GSTP1) 对于清除细胞内ROS的作用至关重要.

研究的目的:

研究GSTP1在CAR-T细胞衰竭中的作用.
确定BLIMP1和GSTP1之间的监管关系.
评估在CAR-T细胞中GSTP1过度表达的治疗潜力.

主要方法:

使用TIMER数据库对GSTP1与耗尽标记的相关性分析.
在患者的PBMC中测量GSTP1,BLIMP1和PD-1表达和体外T细胞耗尽模型.
露西法酶试验和ChIP-qPCR用于阐明GSTP1的BLIMP1调节.
工程制造的CAR-T细胞 (GSTP1 CAR-T,shGSTP1 CAR-T) 的生成和功能评估.

主要成果:

在耗尽的T细胞中,GSTP1的表达下调,而BLIMP1,PD-1和ROS水平增加.
BLIMP1被确定为GSTP1促进者的负调节者.
GSTP1 CAR-T细胞表现出增强的增殖,细胞毒性,抗氧化能力,细胞因子分泌和减少的亡.
在体内研究表明GSTP1 CAR-T细胞具有优越的抗瘤能力.

结论:

BLIMP1直接抑制GSTP1转录,导致T细胞耗尽.
过度表达GSTP1增强了CAR-T细胞的抗瘤活性,并维持了氧化还原平衡.
在改善CAR-T细胞免疫疗法策略方面,GSTP1是一个有前途的目标.

关键词:

一个明亮的眼睛.卡特-T细胞的耗尽这是一个GSTP1GSTP1.氧化应激是一种氧化应激.有活性氧物种的反应性氧物种.

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.